Zuozhou Ning
Papers
2
Total Citations
27
H-Index
2
About
Zuozhou Ning is a rising leader at the intersection of automated synthesis and pharmaceutical chemistry, with a focus on accelerating the discovery and production of complex therapeutic molecules. His work centers on developing robotic platforms and flow chemistry systems to overcome long-standing bottlenecks in drug development. In his highly cited 2023 review, Ning systematically mapped the transformative role of automated flow chemistry in pharmaceutical compound synthesis, establishing a critical framework for the field. His most notable achievement is the creation of CycloBot, a robotic system that enables the automated rapid synthesis of high-purity head-to-tail cyclic peptides using a novel diaminonicotinic acid scaffold. This breakthrough directly addresses a key challenge in peptide therapeutics: cyclic peptides combine the stability and specificity of biologics with the synthetic versatility of small molecules, yet their chemical synthesis has historically been slow and inefficient compared to ribosomal production. By automating this process, Ning’s work promises to dramatically accelerate the development of next-generation peptide drugs. With over 27 citations to his key papers and a growing portfolio of innovative methodologies, Zuozhou Ning is establishing himself as a pivotal figure in the future of automated pharmaceutical synthesis.
Research Focus
Key Achievements
Top Papers
- 1
- 2